Indian Industry Plus A Pratisrutiplus Suppliment

The Ministry of Food Processing Industries (MoFPI) has been implementing an umbrella scheme, namely, Pradhan Mantri Kisan Sampada Yojana (PMKSY) since 2017-18 across the country. PMKSY is a comprehensive package of sub-schemes viz. (i)  Mega Food Parks, (ii) Integrated Cold Chain and Value Addition Infrastructure, (iii) Food Safety & Quality Assurance Infrastructure, (iv) Creation/ Expansion of Food Processing and Preservation ...

The Ministry of Statistics and Programme Implementation brings out data on various aspects of registered manufacturing sectors including food processing sector through the Annual Survey of Industries. As per the latest Annual Survey of Industries (ASI) 2019-20, 41481 food processing units existed in the country.  The State-wise details are attached as Annexure. As per Directorate of Commercial Intelligence and Statistics (DGCIS) ...

Ministry of Statistics and Programme Implementation releases data on various aspects including employment of registered manufacturing sectors including food processing sector through the Annual Survey of Industries(ASI). As per the latest Annual Survey of Industries 2019-20, food processing sector contributed 12.22% of total persons engaged in the registered manufacturing sector. The details of employment in food processing sector for last ...

The Government has put in place a Uniform Code for Pharmaceutical Marketing Practices (UCPMP) for Pharmaceutical companies, which is in operation since 01.01.2015, to prevent unethical practices by the pharmaceutical companies. This code governs the conduct of pharmaceutical companies in their marketing practices, duly covering the various aspects such as medical representatives, textual and audio-visual promotional materials, samples, gifts, etc. ...

MSMEs have availed the benefit under erstwhile PTUAS scheme. However, the PTUAS has been incorporated as a sub-scheme under the Scheme – Strengthening of Pharmaceutical Industry (SPI), which was launched in July 2022. The Strengthening of Pharmaceutical Industry (SPI), with the financial outlay of Rs. 500 crores and with a tenure from FY 2021-2022 to FY 2025-26, has following three components, ...

The Government has put in place a Uniform Code for Pharmaceutical Marketing Practices (UCPMP) for Pharmaceutical companies, which is in operation since 01.01.2015, to prevent unethical practices by the pharmaceutical companies. This code governs the conduct of pharmaceutical companies in their marketing practices, duly covering the various aspects such as medical representatives, textual and audio-visual promotional materials, samples, gifts, etc. ...

Coal production from coal blocks during April-November of Financial year 2022-23 was reviewed by Shri Amrit Lal Meena, Secretary (Coal) here today with project proponents of operational coal blocks. Secretary (coal) informed that the target for the country is 900 million ton and contribution of captives/ commercial mines is significant and he hoped that they will produce as per target.  ...

In order to meet the challenges presented by this unprecedented growth in air traffic, the Airports Authority of India is undertaking development of infrastructure at the airports, depending upon the commercial viability, traffic demand, availability of land etc. Further, in order to boost the growth in the aviation sector, AAI and other private airport operators have taken up the development ...

There is no shortage of pilots in India. There is, however, shortage of Type rated Commanders/PIC (Pilot-in-command) on certain types of aircraft and the same is being managed by utilising foreign pilots by issuing Foreign Aircrew Temporary Authorization (FATA). Presently, there are 82 FATA holders in India. Foreign pilots are issued Foreign Aircrew Temporary Authorization (FATA) under the provisions of ...

The results of the study by the Tata Memorial Centre show that a commonly available and inexpensive drug, carboplatin, increased the cure rate and survival of a very aggressive type of breast cancer, called triple-negative breast cancer, especially among young women who have this disease. Until the results of this study there was no conclusive evidence that this drug should ...